Yimingcare Biomedical Technology Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $7.38M

  • Investors
  • 1

Yimingcare Biomedical Technology General Information

Description

Manufacturer of macromolecular drugs designed for cardiovascular and metabolic diseases. The company utilizes a technology platform to produce macromolecular drugs with genetically engineered extracellular domains that enhance binding and blocking activity against specific ligands, enabling healthcare providers to offer treatment options for pulmonary arterial hypertension and metabolic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Number 15-16, Lane 1000, Zhangheng Road
  • China Pilot Free Trade Zone
  • Shanghai, 201210
  • China
+86 021
Primary Industry
Drug Discovery
Corporate Office
  • 1st Floor, Number 15-16, Lane 1000, Zhangheng Road
  • China Pilot Free Trade Zone
  • Shanghai, 201210
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yimingcare Biomedical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 06-Aug-2026 $7.38M Completed Generating Revenue
To view Yimingcare Biomedical Technology’s complete valuation and funding history, request access »

Yimingcare Biomedical Technology Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yongkan Investment Venture Capital Minority
To view Yimingcare Biomedical Technology’s complete investors history, request access »

Yimingcare Biomedical Technology FAQs

  • When was Yimingcare Biomedical Technology founded?

    Yimingcare Biomedical Technology was founded in 2024.

  • Where is Yimingcare Biomedical Technology headquartered?

    Yimingcare Biomedical Technology is headquartered in Shanghai, China.

  • What industry is Yimingcare Biomedical Technology in?

    Yimingcare Biomedical Technology’s primary industry is Drug Discovery.

  • Is Yimingcare Biomedical Technology a private or public company?

    Yimingcare Biomedical Technology is a Private company.

  • What is the current valuation of Yimingcare Biomedical Technology?

    The current valuation of Yimingcare Biomedical Technology is .

  • What is Yimingcare Biomedical Technology’s current revenue?

    The current revenue for Yimingcare Biomedical Technology is .

  • How much funding has Yimingcare Biomedical Technology raised over time?

    Yimingcare Biomedical Technology has raised $7.38M.

  • Who are Yimingcare Biomedical Technology’s investors?

    Yongkan Investment has invested in Yimingcare Biomedical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process